Helicobacter pylori (H. pylori) infection, which affects approximately half of the world's
population, remains a serious public health problem. As H. pylori infection leads to a number …

Background We previously showed rising primary antibiotic resistance of Helicobacter pylori
during 1990–2015 in the Asia-Pacific region. However, whether primary antibiotic resistance …

Background: Helicobacter pylori (H. pylori) infection is an infectious disease with a
prevalence rate of up to 50% worldwide. It can cause indigestion, gastritis, peptic ulcer, and …

Gastric cancer is a leading cause of cancer-related deaths in China. Affecting more than
40% of the world's population, Helicobacter pylori is a major risk factor for gastric cancer …

Helicobacter pylori, a gram-negative microaerophilic pathogen, causes several upper
gastrointestinal diseases, such as chronic gastritis, peptic ulcer disease, and gastric cancer …

Helicobacter pylori infection causes chronic gastritis, which can progress to severe
gastroduodenal pathologies, including peptic ulcer, gastric cancer and gastric mucosa …

Background Recent clinical trials have evaluated the efficacy of vonoprazan‐amoxicillin
(VA) dual therapy as the first‐line treatment for Helicobacter pylori infection in different …

Purpose To determine the role of Lactobacillus strains and their combinations in inhibiting
the colonization of H. pylori and gastric mucosa inflammation. Methods Human gastric …

Helicobacter pylori is one of the most common cause of human infections. Infected patients
develop chronic active gastritis in all cases, which can lead to peptic ulcer, atrophic gastritis …

Background Levofloxacin-based therapy or bismuth-based quadruple therapy are the
recommended second-line regimens for Helicobacter pylori eradication after failure of …